Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
relapsed/refractory multiple myeloma,multiple myeloma,allogeneic stem cell transplantation,allogeneic hct
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要